We accepted shares of CVS Health (CVS) last week, expecting to sell calls against them. However, the runup in the stock this week has us sitting on a profit.
Trading in COVID-19 vaccine-related stocks has been uneven today — with Moderna (MRNA) and Pfizer (PFE) getting hit, while CVS is up. For that reason, I am recommending booking a profit now. We may trade CVS again soon.
Current Stock Price: $84.46
Cost Basis: $82.24
Action: Sell shares at market
Profit: $2.22, or $222 per 100 shares